- Filed
- May 21, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · May 20, 2026 | 120.16M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 108.49M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 108.49M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 92.93M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 92.14M sh |
| Operating Cash Flow | Q3 2026 · Mar 31, 2026 | −$6.06M |
| Operating Cash Flow | Q3 2026 · Mar 31, 2025 | −$6.14M |
| Cash And Equivalents | Q3 2026 · Mar 31, 2026 | $82.63K |
| Cash And Equivalents | Q3 2026 · Jun 30, 2025 | $172.79K |
| Stockholders Equity | Q3 2026 · Mar 31, 2026 | −$20.88M |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | −$6.75M |
| Current Liabilities | Q3 2026 · Mar 31, 2026 | $29.9M |
| Current Liabilities | Q3 2026 · Jun 30, 2025 | $15.74M |
| Total Liabilities | Q3 2026 · Mar 31, 2026 | $38.54M |
| Total Liabilities | Q3 2026 · Jun 30, 2025 | $25.05M |
| Current Assets | Q3 2026 · Mar 31, 2026 | $7.95M |
| Current Assets | Q3 2026 · Jun 30, 2025 | $7.74M |
| Total Assets | Q3 2026 · Mar 31, 2026 | $17.72M |
| Total Assets | Q3 2026 · Jun 30, 2025 | $18.36M |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | −$0.04 |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | −$0.14 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | −$0.05 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | −$0.19 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | −$0.04 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | −$0.14 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | −$0.05 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | −$0.19 |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $4.06M |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $14.64M |
| Sga Expense | Q3 2026 · Mar 31, 2025 | $5.34M |
| Sga Expense restated | Q3 2026 · Mar 31, 2025 | $18.11M |
| Rd Expense | Q3 2026 · Mar 31, 2026 | $0 |
| Rd Expense | Q3 2026 · Mar 31, 2026 | $0 |
| Rd Expense | Q3 2026 · Mar 31, 2025 | $0 |
| Rd Expense | Q3 2026 · Mar 31, 2025 | $0 |
| Net Income | Q3 2026 · Mar 31, 2026 | −$4.33M |
| Net Income | Q3 2026 · Mar 31, 2026 | −$14.8M |
| Net Income | Q3 2026 · Mar 31, 2025 | −$4.2M |
| Net Income | Q3 2026 · Mar 31, 2025 | −$17.72M |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$3.28M |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$12.18M |
| Operating Income | Q3 2026 · Mar 31, 2025 | −$3.94M |
| Operating Income restated | Q3 2026 · Mar 31, 2025 | −$14.71M |
| Gross Profit | Q3 2026 · Mar 31, 2026 | $780.44K |
| Gross Profit | Q3 2026 · Mar 31, 2026 | $2.47M |
| Gross Profit | Q3 2026 · Mar 31, 2025 | $1.4M |
| Gross Profit | Q3 2026 · Mar 31, 2025 | $3.4M |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $1.79M |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $7.46M |
| Cost Of Revenue | Q3 2026 · Mar 31, 2025 | $3.17M |
| Cost Of Revenue | Q3 2026 · Mar 31, 2025 | $10.32M |
| Revenue | Q3 2026 · Mar 31, 2026 | $2.57M |
| Revenue | Q3 2026 · Mar 31, 2026 | $9.93M |
| Revenue | Q3 2026 · Mar 31, 2025 | $4.57M |
| Revenue | Q3 2026 · Mar 31, 2025 | $13.72M |